COVID-19 in Pediatric Patients: A Focus on CHD Patients
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2 virus. As of the 30th of September 2020, around 34,000,000 cases have been reported globally. Pediatrics with underlying congenital heart disease represent a small yet a critical proportion of these patients. In general, t...
Main Authors: | Rana O. Zareef, Nour K. Younis, Fadi Bitar, Ali H. Eid, Mariam Arabi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.612460/full |
Similar Items
-
COVID-19 in congenital heart disease patients: what did we learn?!
by: Rana Zareef, et al.
Published: (2023-08-01) -
Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01) -
Congenital heart disease research landscape in the Arab world: a 25-year bibliometric review
by: Fouad Bitar, et al.
Published: (2024-01-01) -
Editorial: Next research perspectives in pediatric cardiology for imaging and interventions
by: Olivier Villemain, et al.
Published: (2022-08-01) -
Corticosteroids in COVID-19: pros and cons
by: Aymen Bahsoun, et al.
Published: (2023-08-01)